Tobacco use is the leading cause of preventable disease and death in the world, but most attempts to quit are unsuccessful. Atul Jain, MD, assistant professor of medicine at Mayo College of Medicine, discusses new guidelines from the American Thoracic Society on pharmacologic management of tobacco cessation, including target population and deciding when to initiate.
Related Article(s):
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults
Fler avsnitt av JAMA Clinical Reviews
Visa alla avsnitt av JAMA Clinical ReviewsJAMA Clinical Reviews med JAMA Network finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
